Biotech stocks are down, but there are hidden gems among the rubble. Get in now before the broader market finds them. More
Articles
Why Investors Should Steer Clear of This Beleagured Beer Stock BUD Stock
Since Anheuser-Busch Inbev’s massive acquisition of SABMiller in 2016, BUD stock has lost more than half its value. There’s a good reason. More
Tilray Stock’s Tumble: A Buying Opportunity or a Cautionary Tale?
The cannabis sector is one that's been absolutely crushed of late. Can investors in Tilray and TLRY stock make it out ahead? More